Vorinostat-An Overview.
Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy.
Consultant Dermatologist, Kedar Hospital, Chennai, Tamil Nadu, India.
Aditya Kumar
AK
Bubna
Cutaneous T cell lymphoma; Vorinostat; histone deacytelase inhibitor